Literature DB >> 34014805

Gene editing isn't just about food: comments from U.S. focus groups.

Brandon R McFadden1, Joy N Rumble2, Kathryn A Stofer3, Kevin M Folta4, Savanna Turner3, Adam Pollack1.   

Abstract

In the United States, adult public perception of genetic modification has been well documented in the domain of agriculture and food; however, recent international news on gene editing in medical applications may present new challenges for science communicators who seek to proactively share benefits of emerging gene editing technology. While research traditionally considers perceptions of agricultural and medical applications separately, gene editing may bridge the gap between the two domains. We find that when asked about thoughts regarding gene editing, adult focus groups discussed medical applications more frequently and extensively than agricultural applications. Although, when examining the length of discussion about specific topics, designer babies, cures for disease, and food were discussed at similar lengths. Understanding audiences' current perceptions of the technology is the first step in shaping strategic communication efforts to inform public opinion. A proper understanding of the benefits and risks of new technology is central to its application.

Entities:  

Keywords:  Genome editing; designer babies; disease; food; science communication

Mesh:

Year:  2021        PMID: 34014805      PMCID: PMC9208619          DOI: 10.1080/21645698.2021.1919485

Source DB:  PubMed          Journal:  GM Crops Food        ISSN: 2164-5698            Impact factor:   3.118


  15 in total

1.  Worlds apart? The reception of genetically modified foods in Europe and the U.S.

Authors:  G Gaskell; M W Bauer; J Durant; N C Allum
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

Review 2.  Focus-group interview and data analysis.

Authors:  Fatemeh Rabiee
Journal:  Proc Nutr Soc       Date:  2004-11       Impact factor: 6.297

3.  What's next for science communication? Promising directions and lingering distractions.

Authors:  Matthew C Nisbet; Dietram A Scheufele
Journal:  Am J Bot       Date:  2009-09-03       Impact factor: 3.844

4.  Genome-edited baby claim provokes international outcry.

Authors:  David Cyranoski; Heidi Ledford
Journal:  Nature       Date:  2018-11       Impact factor: 49.962

5.  Factors influencing U.S. consumer support for genetic modification to prevent crop disease.

Authors:  Katherine A McComas; John C Besley; Joseph Steinhardt
Journal:  Appetite       Date:  2014-03-13       Impact factor: 3.868

6.  Genetics experience impacts attitudes towards germline gene editing: a survey of over 1500 members of the public.

Authors:  Abbie Jedwab; Danya F Vears; Cheryl Tse; Christopher Gyngell
Journal:  J Hum Genet       Date:  2020-07-31       Impact factor: 3.172

7.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

Authors:  Haydar Frangoul; David Altshuler; M Domenica Cappellini; Yi-Shan Chen; Jennifer Domm; Brenda K Eustace; Juergen Foell; Josu de la Fuente; Stephan Grupp; Rupert Handgretinger; Tony W Ho; Antonis Kattamis; Andrew Kernytsky; Julie Lekstrom-Himes; Amanda M Li; Franco Locatelli; Markus Y Mapara; Mariane de Montalembert; Damiano Rondelli; Akshay Sharma; Sujit Sheth; Sandeep Soni; Martin H Steinberg; Donna Wall; Angela Yen; Selim Corbacioglu
Journal:  N Engl J Med       Date:  2020-12-05       Impact factor: 91.245

8.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

9.  The CRISPR-baby scandal: what's next for human gene-editing.

Authors:  David Cyranoski
Journal:  Nature       Date:  2019-02       Impact factor: 69.504

Review 10.  Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine.

Authors:  Iwona Pranke; Anita Golec; Alexandre Hinzpeter; Aleksander Edelman; Isabelle Sermet-Gaudelus
Journal:  Front Pharmacol       Date:  2019-02-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.